Skip to content
Polynoma Logo
  • Home
  • About Us
  • Technology
  • Clinical Trials
    • Phase III Study
    • Phase II Studies
  • Publications
  • News
  • Contact

News

June 23rd, 2020

Polynoma Receives FDA Fast Track Designation for its Melanoma Cancer Vaccine Seviprotimut-L

May 13th, 2020

Polynoma Presenting Final Analysis of MAVIS Phase III Part B1 Data of Its Investigational Melanoma Vaccine, Seviprotimut-L, at ASCO20 Virtual Scientific Program

November 06th, 2019

Polynoma Presenting Interim Phase III Data for Its Investigational Melanoma Vaccine, Seviprotimut-L, at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting


TERMS OF USE | PRIVACY POLICY

© 2021 Polynoma LLC. All rights reserved.